EUVIMEDEUVIMED entdecken
Open Access

In Situ Single‐Particle LSPR Biosensor for Amplification‐Free Detection of miR‐451 via Dark‐Field Scattering Spectroscopy

Xingyu Zi, Hongen Cheng, Jianqi Wang, Kuilin Liu, Xinyu Gao, Guohua Liu iD, Mingqing Zhang

Small · 2026

DOI: 10.1002/smll.202509831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Xingyu Zi und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Electronic Information and Optical Engineering, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: MicroRNAs, Surface Plasmon Resonance, Biosensing Techniques. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is frequently diagnosed at advanced stages due to the asymptomatic nature of early disease and the semi‐invasive nature of colonoscopy. Developing effective noninvasive methods for CRC‐related biomarker detection is crucial for reducing CRC mortality. Notably, miR‐451 has been reported as a CRC‐related biomarker candidate. We present an in situ single‐particle spectroscopic assay for amplification‐free quantitative detection of miR‐451 using gold nanoparticles (AuNPs). Functionalized substrates with immobilized AuNPs enable real‐time monitoring of localized surface plasmon resonance (LSPR) peak shifts at the single‐particle level. By statistically analyzing the proportion of AuNPs exhibiting LSPR shifts, we achieved quantitative detection of miR‐451. This in situ microfluidic configuration allows spectral analysis of the same nanoparticles before and after detection, eliminating spatial sampling errors. Specificity is conferred by a stem‐loop DNA probe on the AuNP surface via strand displacement. The main advance lies in in situ tracking of the same immobilized nanoparticles with statistical single‐particle readout. This strategy demonstrates a detection limit of 58 f m and excellent specificity against other miRNAs, with proof‐of‐concept feasibility in spiked FBS samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsSurface Plasmon ResonanceBiosensing TechniquesMetal NanoparticlesGoldHumans

Stichwörter der Autor:innen

AuNPsin situ detectionlocalized surface plasmon resonancemiR‐451

Substanzen

MicroRNAsGoldMIRN451 microRNA, human

Autor:innen und Institutionen

  • College of Electronic Information and Optical Engineering, Nankai University, Tianjin, China.
  • Tianjin Key Laboratory of Optoelectronic Sensor and Sensing Network Technology, Tianjin, China.
  • Department of Colorectal Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.
  • Engineering Research Center of Thin Film Optoelectronics Technology, Ministry of Education, Nankai University, Tianjin, China.

ORCID-Profile: Guohua Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zi, X., Cheng, H., Wang, J., Liu, K., Gao, X., Liu, G., & Zhang, M. (2026). In Situ Single‐Particle LSPR Biosensor for Amplification‐Free Detection of miR‐451 via Dark‐Field Scattering Spectroscopy. Small. https://doi.org/10.1002/smll.202509831

Vancouver

Zi X, Cheng H, Wang J, Liu K, Gao X, Liu G, et al. In Situ Single‐Particle LSPR Biosensor for Amplification‐Free Detection of miR‐451 via Dark‐Field Scattering Spectroscopy. Small. 2026. doi:10.1002/smll.202509831

BibTeX
@article{Zi2026,
  author = {Zi, Xingyu and Cheng, Hongen and Wang, Jianqi and Liu, Kuilin and Gao, Xinyu and Liu, Guohua and Zhang, Mingqing},
  title = {In Situ Single‐Particle LSPR Biosensor for Amplification‐Free Detection of miR‐451 via Dark‐Field Scattering Spectroscopy},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.202509831}
}
Kostenlos starten →